Clinical Trial

Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2023 (before its estimated September 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Primary immunodeficiencies (PID) are a heterogeneous group of diseases that occur as a result of disorders that affect the development, differentiation and/or function of various cells and building blocks in the immune system. Among the symptoms and complications of PID, pulmonary complications are very common and significantly increase the morbidity and mortality of the disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-14.
Status change: Not Yet Recruiting → Recruiting 2023-12-03
Trial Details
NCT Number NCT06092528
Lead Sponsor Gazi University
Conditions Primary Immunodeficiency
Enrollment 40 participants
Start Date 2023-11-01
Primary Completion 2025-09-20 (estimated)
Study Completion 2026-09-20 (estimated)
Updated on ClinicalTrials.gov 2023-12-05